Continued research is needed to identify the specific molecular mechanisms linking SMN deficiency to downstream target genes alteration and, secondarily, those genes’ relative contributions to the SMA phenotype in a mouse model of the disease. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.